Over the past a long time, the volume of patients referred for allogeneic hematopoietic cell transplantation has dropped noticeably,133 nevertheless the course of action needs to be encouraged to youthful/match sufferers in whom BCR/BCL2 inhibitor cure fails, particularly in Individuals with TP53